<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-BNACMQX9</identifier><date>2021</date><creator>Bešić, Nikola</creator><creator>Drmota, Eva</creator><creator>Kovačević, Nina</creator><creator>Merlo, Sebastjan</creator><relation>documents/doc/B/URN_NBN_SI_doc-BNACMQX9_001.pdf</relation><relation>documents/doc/B/URN_NBN_SI_doc-BNACMQX9_001.txt</relation><format format_type="type">article</format><format format_type="extent">str. 1-7</format><identifier identifier_type="DOI">10.2478/raon-2021-0013</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID_HOST">53289475</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-BNACMQX9</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">CA-125</subject><subject language_type_id="eng">neoadjuvant chemotherapy</subject><subject language_type_id="slv">neoadjuvantna kemoterapija</subject><subject language_type_id="eng">ovarian cancer</subject><subject language_type_id="slv">rak jajčnikov</subject><subject language_type_id="slv">tumorski označevalci</subject><subject language_type_id="eng">tumour marker</subject><title>Preoperative serum CA-125 level as a predictor for the extent of cytoreduction in patients with advanced stage epithelial ovarian cancer</title></Record>